Biotech · Private company
Geneos Therapeutics
Track this companyFree. Adds Geneos Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- CELLECTRA®2000 EP DevicePhase 2 · HCCClinicalTrials.gov · fetched Nov 12, 2026
- Electroporation DevicePhase 2 · HCCClinicalTrials.gov · fetched Nov 12, 2026
- GNOS-PV02Phase 2 · HCCClinicalTrials.gov · fetched Nov 12, 2026
- GNOS-PV02 + INO-9012 delivered by intradermal injection, followed by electroporationPhase 2 · HCCClinicalTrials.gov · fetched Nov 12, 2026
- INO-9012Phase 2 · HCCClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · HCCClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCCPHASE2 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07722741 · fetched Nov 12, 2026
- Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated GlioblastomaPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 14, 2020ClinicalTrials.gov NCT04015700 · fetched Nov 12, 2026
- GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCCPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 1, 2020ClinicalTrials.gov NCT04251117 · fetched Nov 12, 2026